Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05750732
Other study ID # GO 22/1321
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 20, 2023
Est. completion date February 1, 2026

Study information

Verified date August 2023
Source Hacettepe University
Contact Hande Gül Ulusoy Gezer, MSc
Phone +905357314604
Email handegululusoy@hacettepe.edu.tr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this observational study is to investigate the relationship of CLOCK 3111T/C (rs1801260) gene variant with nutritional habits, nutritional status, chronotype, sleep quality, some biochemical parameters in overweight or obese individuals and to observe its effect on weight loss diet intervention. The main questions it aims to answer are: - Is the frequency of carrying the CLOCK 3111T/C (rs1801260) gene risk allele different between individuals with normal body weight and those who are overweight or obese? - Do those with the CLOCK 3111T/C (rs1801260) risk allele have a higher frequency of evening chronotype and a shorter sleep duration? - Is the effect of CLOCK 3111T/C (rs1801260) gene alleles different on weight loss diet response in overweight or obese individuals? A questionnaire will be applied to the individuals in both groups (normal body weight and overweight/obese individuals) to evaluate their general characteristics, eating habits, adherence to Mediterranean diet, DASH and MIND. In addition, anthropometric measurements, 3-day food consumption record and 3-day physical activity record will be taken from individuals. CLOCK 3111T/C (rs1801260) gene variant analysis in whole blood, adiponectin and leptin hormones in serum samples will be studied. Participants those who are overweight/obese will be asked to follow a weight loss diet for 3 months. Researchers will compare participants with normal body weight and those who are overweight or obese to see if there is a difference between the frequency of carrying the CLOCK 3111T/C (rs1801260) gene risk allele.


Recruitment information / eligibility

Status Recruiting
Enrollment 400
Est. completion date February 1, 2026
Est. primary completion date February 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: - Be in the 20-50 age range - BMI in the range of 25-40 kg/m2 for the study group - BMI of 18.5-24.9 kg/m2 for the control group Exclusion Criteria: - Those with type 1 diabetes - Those with Type 2 diabetes who take insulin therapy or use oral diabetes medication - Those who use drugs for weight loss - Those with unstable cardiovascular disease - Those with kidney or liver failure - Presence of diagnosed malabsorption (celiac disease, Crohn's, ulcerative colitis) - Those who have undergone bariatric surgery - Those who are pregnant or breastfeeding - Menopausal women - Those who use corticosteroids - Those with severe endocrine disorders (hypothyroidism, hyperthyroidism, hypopituitarism) - Those with psychiatric or neurological disease - Weight change of >5% in the last 6 months - Those with malignant tumors - Those with eating disorders - Shift workers - Relatives - People from different ethnic backgrounds

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Weight loss diet
Participants in the study group will be given training on the weight loss diet, which is a routine part of their treatment.

Locations

Country Name City State
Turkey Hacettepe University Ankara

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in body weight Body weight (kg) at 12 weeks minus weight at baseline (kg) Baseline to 12 weeks
Primary Change in dietary energy and nutrient intakes Energy and nutrients intakes will be assessed using a dietary recall method at baseline, 4th week, 8th week and at end of the intervention Baseline to 12 weeks
Primary Circadian CLOCK gene polymorphism Comparative analysis of the frequency distributions of genotypes and alleles of 3111T/C CLOCK gene polymorphism will be carried out both in study and control group 1 day
Secondary Change in sleep quality Using 19-item Pittsburg Sleep Quality Index (PSQI) Baseline to 12 weeks
Secondary Change in adherence to Mediterranean diet Using the 14-item Mediterranean Diet Adherence Screener (MEDAS) Baseline to 12 weeks
Secondary Change in adherence to DASH Using the 11-item Dietary Approaches to Stop Hypertension-Quality (DASH-Q) Baseline to 12 weeks
Secondary Change in adherence to MIND Using the 14-item The Mediterranean-DASH Diet Intervention for Neurodegenerative Delay (MIND) score Baseline to 12 weeks
Secondary Change in chronotype Using the 19-item The Morningness-Eveningness Questionnaire (MEQ) Baseline to 12 weeks
Secondary Change in eating behaviors Using the 18-item The Three-Factor Eating Questionnaire (TFEQ-18) Baseline to 12 weeks
Secondary Change in night eating behaviors Using the 16-item The Night Eating Questionnaire (NEQ) Baseline to 12 weeks
Secondary Change in serum adiponectin and leptin level Using ELISA kits Baseline to 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2